First AD

Second AD

Multiple Sclerosis

EMD-22-NRD0193 - /clinical/multiple-sclerosis

 multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related disorders such as neuromyelitis optica spectrum disorder.

EAN News Network

The News Network video series features a variety of clinicians providing updates on the major data and paradigm-affecting updates from societal meetings and conferences focused on patients with neurologic diseases.

News Network

A multiple sclerosis expert, Dr Brownlee shares study design and clinical data on relapse following discontinuation of ozanimod in patients with multiple sclerosis.

Relapse Following Discontinuation of Ozanimod

Brain and Cognitive Changes in Multiple Sclerosis

Association Between Brain Volume and Long-term Cognition in  Relapsing Multiple Sclerosis

Cognitive Care Recommendations

Factors Necessitating Treatment Change in Multiple Sclerosis

Ozanimod in DMT Naïve vs Experienced Patients with Relapsing Multiple Sclerosis

Clinical Pearls for MS Management in Everyday Practice

Treatment Discontinuation in Multiple Sclerosis

Implications of Ozanimod Discontinuation Data for MS Care

Managing Relapses in Patients With Multiple Sclerosis

Long-Term Outcomes With Ozanimod Based on Number of MS Relapses

Advice for Clinical Management of Multiple Sclerosis

Relapse Following Discontinuation of Ozanimod

Latest News